Riccardo Vincenzo Mancuso
Overview
Explore the profile of Riccardo Vincenzo Mancuso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sommer-Pluss C, Leiggener C, Nikci E, Mancuso R, Rabbani S, Lamers C, et al.
Biomolecules
. 2025 Feb;
15(2).
PMID: 40001541
The family of the β-integrin receptors is critically involved in host defense and homeostasis, by mediating immune cell adhesion, migration, and phagocytosis. Due to their key roles in immune surveillance...
2.
Abegg V, Panajatovic M, Mancuso R, Allard J, Duthaler U, Odermatt A, et al.
Toxicol Lett
. 2024 Jan;
393:1-13.
PMID: 38219807
St. John's Wort preparations are used for the treatment of mild to moderate depression. They are usually well tolerated but can cause adverse reactions including liver toxicity in rare cases....
3.
Bolten J, Mancuso R, Roos N, Mayr A, Puligilla R, Kraus L, et al.
Toxicol Appl Pharmacol
. 2023 Mar;
466:116493.
PMID: 36977437
Iopamidol is a nonionic, low-osmolar iodinated contrast agent used for angiography. Its clinical use is associated with renal dysfunction. Patients suffering from preexisting kidney disease have an increased risk of...
4.
Hauswirth P, Graber P, Buczak K, Mancuso R, Schenk S, Nuesch J, et al.
Viruses
. 2023 Jan;
15(1).
PMID: 36680249
Oncotoxic proteins such as the non-structural protein 1 (NS1), a constituent of the rodent parvovirus H1 (H1-PV), offer a novel approach for treatment of tumors that are refractory to other...
5.
Roos N, Mancuso R, Sanvee G, Bouitbir J, Krahenbuhl S
Food Chem Toxicol
. 2022 Feb;
162:112869.
PMID: 35182693
The tyrosine kinase inhibitors (TKIs) imatinib and lapatinib are associated with severe hepatotoxicity, whose mechanisms are currently under investigation. As amphiphilic drugs, imatinib and lapatinib enrich in lysosomes. In the...